A Novel Peptide from T-Cell Leukemia Translocation-Associated Gene (TCTA) Protein Inhibits Proliferation of a Small-Cell Lung Carcinoma


In 2009, we demonstrated that a peptide, which we named Peptide A, derived from the extracellular domain of T-cell leukemia translocation-associated gene (TCTA) protein, inhibited both RANKL-induced human osteoclastogenesis and pit formation of mature human osteoclasts. Here, we examined the effect of Peptide A on the cell proliferation of cell lines of small-cell lung carcinoma, breast cancer, and prostate cancer: RERF-LC-MA, MCF-7, and PC-3, respectively. Peptide A inhibited the proliferation of RERF-LC-MA, but not MCF-7 or PC-3. TCTA protein was immunohistologically detected in RERF-LC-MA and MCF-7. Thus, Peptide A may provide a novel strategy for the therapy of the patients with small-cell lung carcinoma, especially with bone metastasis. In addition, Peptide A may be useful for the treatment of various cancer patients with bone metastasis.

Share and Cite:

Kotake, S. , Kawamoto, T. and Nanke, Y. (2013) A Novel Peptide from T-Cell Leukemia Translocation-Associated Gene (TCTA) Protein Inhibits Proliferation of a Small-Cell Lung Carcinoma. Journal of Cancer Therapy, 4, 44-46. doi: 10.4236/jct.2013.48A007.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] P. D. Aplan, B. E. Johnson, E. Russell, D. S. Chervinsky and I. R. Kirsch, “Cloning and Characterization of TCTA, a Gene Located at the Site of at (1;3) Translocation,” Cancer Research, Vol. 55, No. 9, 1995, pp. 1917-1921.
[2] J. F. Rual, K. Venkatesan, T. Hao, T. Hirozane-Kishikawa, A. Dricot, N. Li, G. F. Berriz, F. D. Gibbons, M. Dreze, N. Ayivi-Guedehoussou, N. Klitgord, C. Simon, M. Boxem, S. Milstein, J. Rosenberg, D. S. Goldberg, L. V. Zhang, S. L. Wong, G. Franklin, S. Li, J. S. Albala, J. Lim, C. Fraughton, E. Llamosas, S. Cevik, C. Bex, P. Lamesch, R. S. Sikorski, J. Vandenhaute, H. Y. Zoghbi, A. Smolyar, S. Bosak, R. Sequerra, L. Doucette-Stamm, M. E. Cusick, D. E. Hill, F. P. Roth and M. Vidal, “Towards a Proteome-Scale Map of the Human Protein-Protein Interaction Network,” Nature, Vol. 437, No. 7062, 2005, pp. 1173-1178. doi:10.1038/nature04209
[3] S. Kotake, Y. Nanke, M. Kawamoto, T. Yago, N. Udagawa, N. Ichikawa, T. Kobashigawa, S. Saito, S. Momohara, N. Kamatani and H. Yamanaka, “T-Cell Leukemia Translocation-Associated Gene (TCTA) Protein Is Required for Human Osteoclastogenesis,” Bone, Vol. 45, No. 4, 2009, pp. 627-639. doi:10.1016/j.bone.2009.06.019
[4] S. Kotake, N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, T. J. Martin and T. Suda, “IL-17 in Synovial Fluids from Patients with Rheumatoid Arthritis Is a Potent Stimulator of Osteoclastogenesis,” The Journal of Clinical Investigation, Vol. 103, No. 9, 1999, pp. 1345-1352. doi:10.1172/JCI5703
[5] J. Costa-Rodrigues, K. A. Moniz, M. R. Teixeira and M. H. Fernandes, “Variability of the Paracrine-Induced Osteoclastogenesis by Human Breast Cancer Cell Lines,” Journal of Cellular Biochemistry, Vol. 113, No. 3, 2012, pp. 1069-1079. doi:10.1002/jcb.23439

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.